Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
01 1Bachem Americas, Inc.
01 1Corticorelin Ovine Triflutate
01 1Switzerland
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
NDC Package Code : 52416-102
Start Marketing Date : 1996-05-23
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Corticorelin ovine triflutate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Corticorelin ovine triflutate, including repackagers and relabelers. The FDA regulates Corticorelin ovine triflutate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Corticorelin ovine triflutate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Corticorelin ovine triflutate supplier is an individual or a company that provides Corticorelin ovine triflutate active pharmaceutical ingredient (API) or Corticorelin ovine triflutate finished formulations upon request. The Corticorelin ovine triflutate suppliers may include Corticorelin ovine triflutate API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Corticorelin ovine triflutate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Corticorelin ovine triflutate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Corticorelin ovine triflutate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Corticorelin ovine triflutate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Corticorelin ovine triflutate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Corticorelin ovine triflutate suppliers with NDC on PharmaCompass.
We have 1 companies offering Corticorelin ovine triflutate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
